SCHEMBL4843191

SCHEMBL4843191

COC(=O)c1ccc(OCCNC(=O)[C@@H]2Cc3ccccc3N2S(=O)(=O)c2ccc(-c3ccc(F)cc3Cl)cc2)cc1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 4/20 0.36
ALDH1A1 P00352 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
GNRHR P30968 1/20 0.36
MMP1 P03956 1/20 0.36
MMP9 P14780 1/20 0.36
MMP13 P45452 1/20 0.36
ADAM17 P78536 1/20 0.36
MAPT P10636 3/20 0.35
MMP8 P22894 4/20 0.35
MMP3 P08254 2/20 0.35
PTGER3 P43115 1/20 0.35
POLB P06746 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA9 Q16790 1/20 0.35
RORC P51449 1/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4838047 0.94 CA12 (0.39) TRPA1ALDH1A1NPSR1MMP1MMP9
SCHEMBL4840897 0.93 MMP8 (0.37) TRPA1ALDH1A1NPSR1MAPTMMP8
SCHEMBL4833271 0.93 MMP1 (0.39) TRPA1ALDH1A1NPSR1MMP1MMP9
SCHEMBL4845004 0.93 MAPT (0.40) TRPA1ALDH1A1NPSR1MMP1MMP9
SCHEMBL4840863 0.92 PTGER3 (0.39) TRPA1ALDH1A1NPSR1GNRHRMAPT
SCHEMBL4833504 0.92 MAPT (0.40) TRPA1ALDH1A1NPSR1MMP1MMP9
SCHEMBL4845437 0.89 MAPT (0.39) TRPA1ALDH1A1NPSR1GNRHRMMP1
SCHEMBL4838705 0.88 FFAR4 (0.38) TRPA1ALDH1A1NPSR1GNRHRMAPT
SCHEMBL4843193 0.88 PTGER3 (0.40) TRPA1MAPTMMP8MMP3PTGER3
SCHEMBL4840886 0.87 MMP8 (0.42) TRPA1ALDH1A1NPSR1GNRHRMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 TRPA1 368/4885ALDH1A1 1819/4885NPSR1 101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.